| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 05/10/2001 | CA2388187A1 Treatment of c. difficile toxin b associated conditions |
| 05/10/2001 | CA2387801A1 Uteroglobin-like polynucleotides, polypeptides, and antibodies |
| 05/10/2001 | CA2387785A1 Human transferase molecules |
| 05/10/2001 | CA2387754A1 10 human secreted proteins |
| 05/10/2001 | CA2387745A1 Positive modulators of nicotinic receptor agonists |
| 05/10/2001 | CA2387741A1 Positive modulators of nicotinic receptor agonists |
| 05/10/2001 | CA2386641A1 32 human secreted proteins |
| 05/10/2001 | CA2385928A1 Agonists specific for the peripheral cannabinoid receptor |
| 05/09/2001 | EP1097945A2 Monoclonal and chimeric antibody specific for human tumor necrosis factor |
| 05/09/2001 | EP1097921A1 Phenylhydrazines |
| 05/09/2001 | EP1097920A1 Intermediate for condensed benzazepine derivatives |
| 05/09/2001 | EP1097193A1 Liver stem cell |
| 05/09/2001 | EP1097167A2 Neurotrophic growth factor |
| 05/09/2001 | EP1097150A1 Imidazolyl derivatives |
| 05/09/2001 | EP1097149A1 Bicyclohexane derivatives |
| 05/09/2001 | EP1097139A1 Quinoline derivatives |
| 05/09/2001 | EP1097137A1 N-substituted naphthalene carboxamides as neurokinin-receptor antagonists |
| 05/09/2001 | EP1096949A2 Treatment of celiac disease with interleukin-15 antagonists |
| 05/09/2001 | EP1096948A1 Use of interleukin-11 to treat gastrointestinal disorders |
| 05/09/2001 | EP1096924A1 Inhibitors of proteasomal activity for stimulating bone and hair growth |
| 05/09/2001 | EP0855397B1 (r)-5-bromo-n-(1-ethyl-4-methylhexahydro-1h-1,4-diazepin-6-yl)-2-methoxy-6-methylamino-3-pyridine-carboxamide, process for producing the same and medicinal composition containing the same |
| 05/09/2001 | CN1294581A Pyridine derivative and pharmaceutical contg. same |
| 05/09/2001 | CN1294518A Remidies for hepatitis |
| 05/09/2001 | CN1294134A Polypeptide structure of shark liver for preventing and curing hepatism and its purifying process |
| 05/09/2001 | CN1294012A Aphtha ointment and its preparing process |
| 05/09/2001 | CN1294011A 'Gumeihuichun Dan' |
| 05/09/2001 | CN1294008A Oral liquid 'Arula' for treating gastrointestinal disease |
| 05/09/2001 | CN1294005A Process for preparing health-care medicine |
| 05/09/2001 | CN1293999A Chinese medicine for detoxicating wound and its preparing process |
| 05/09/2001 | CN1293992A Medicine 'Buyuan Jianmei Wan' |
| 05/09/2001 | CN1293987A Chinese medicine for treating heptitides A and B |
| 05/09/2001 | CN1293986A Prescription of biological preparation |
| 05/09/2001 | CN1293973A Medicine for treating abdominal node and its preparing process |
| 05/09/2001 | CN1293969A 'Tongrundan' pill |
| 05/09/2001 | CN1293962A Oral liquid 'Tongxieting' for treating bromatoxism |
| 05/09/2001 | CN1293956A Preccription for treating gastrosis quickly and radically |
| 05/08/2001 | US6229031 Method for manufacturing rumen bypass feed supplements |
| 05/08/2001 | US6229025 Process for alkylating hindered sulfonamides |
| 05/08/2001 | US6229013 Pyrrolo[3,4-d]pyrimidinone derivatives and their use as medicaments |
| 05/08/2001 | US6228853 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| 05/08/2001 | US6228834 Treating gramnegative bacterial infections; neutralizing lipopolysaccharides |
| 05/08/2001 | US6228642 Antisense oligonucleotide modulation of tumor necrosis factor-(α) (TNF-α) expression |
| 05/08/2001 | US6228619 Glucosaminidase |
| 05/08/2001 | US6228400 Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same |
| 05/08/2001 | US6228387 Integrated comprehensive hemorrhoid treatment compositions and regimen |
| 05/08/2001 | US6228347 Antioxidant gel for gingival conditions |
| 05/08/2001 | CA2170289C A method of treating liver disease and like indications with vasodilating agents |
| 05/08/2001 | CA2095852C Proteins with changed epitopes and methods for the production thereof |
| 05/08/2001 | CA2032330C Benzyl-substituted rhodanine derivatives for treating inflammatory bowel disease |
| 05/08/2001 | CA2017746C A new phenylacetic derivative and process for their obtention |
| 05/03/2001 | WO2001031008A2 Human and rat fgf-20 genes and gene expression products |
| 05/03/2001 | WO2001031006A2 Serum amyloid a isoform from colostrum |
| 05/03/2001 | WO2001030978A1 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 05/03/2001 | WO2001030815A1 Redox reversible hcv proteins with native-like conformation |
| 05/03/2001 | WO2001030812A2 Activation of hcv-specific t cells |
| 05/03/2001 | WO2001030781A2 INHIBITORS OF αLβ2 MEDIATED CELL ADHESION |
| 05/03/2001 | WO2001030774A1 Substituted indoles for modulating nfkb activity |
| 05/03/2001 | WO2001030772A1 Compounds and their use as cysteine protease inhibitors |
| 05/03/2001 | WO2001030767A1 Sodium 2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-(2-(3,4-dimethoxyphenyl)ethoxy)-3,3-diphenylpropionate and use thereof as endothelin antagonist |
| 05/03/2001 | WO2001030766A1 Phthalazinone derivatives as pde 4 inhibitors |
| 05/03/2001 | WO2001030395A1 Antisense modulation of tumor necrosis factor alpha converting enzyme (tace) expression |
| 05/03/2001 | WO2001030393A2 Methods for reducing the effects of cancers that express a33 antigen using a33 antigen specific immunoglobulin products |
| 05/03/2001 | WO2001030375A2 Use of gdnf for treating corneal defects |
| 05/03/2001 | WO2001030353A1 Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders |
| 05/03/2001 | WO2001030343A1 Pharmaceuticals for treating obesity |
| 05/03/2001 | WO2001030329A2 Combinations of lamivudine and entecavir for treatment of hepatitis b virus infuction |
| 05/03/2001 | WO2001030300A2 Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies |
| 05/03/2001 | WO2000074712A3 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product |
| 05/03/2001 | WO2000072876A3 Prevention and treatment of amyloidogenic disease |
| 05/03/2001 | WO2000066107A3 Antimalarian agents for the treatment of asthma |
| 05/03/2001 | WO2000065028A3 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR |
| 05/03/2001 | WO1999059544A3 Orally disintegrable tablets |
| 05/03/2001 | DE19951671A1 2-(4,6-Dimethyl-pyrimidin-2-yloxy)-3-(2-(3,4-dimethoxyphenyl)ethoxy)-3,3-diphenylpropionssäure-Natriumsalz und seine Verwendung als Endothelinantagonist and its use as an endothelin antagonist |
| 05/03/2001 | DE19951360A1 Substituierte Indole Substituted indoles |
| 05/03/2001 | CA2389012A1 Sodium 2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-(2-(3,4-dimethoxyphenyl)ethoxy)-3,3-diphenylpropionate and use thereof as endothelin antagonist |
| 05/03/2001 | CA2388724A1 Oral glutamine in the prevention of neonatal necrotizing enterocolitis and other gastrointestinal mucosal damage |
| 05/03/2001 | CA2388637A1 Human fgf-20 gene and gene expression products |
| 05/03/2001 | CA2388338A1 Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies |
| 05/03/2001 | CA2388121A1 Phthalazinone derivatives as pde 4 inhibitors |
| 05/03/2001 | CA2387907A1 Serum amyloid a isoform from colostrum |
| 05/03/2001 | CA2387666A1 Redox reversible hcv proteins with native-like conformation |
| 05/03/2001 | CA2387506A1 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 05/03/2001 | CA2386750A1 Pharmaceuticals for treating obesity |
| 05/03/2001 | CA2385929A1 Use of gdnf for treating corneal defects |
| 05/02/2001 | EP1096016A1 Platelet-activating factor acetylhydrolase |
| 05/02/2001 | EP1096009A1 G-protein coupled receptor-like Polypeptide |
| 05/02/2001 | EP1096008A2 Human G protein-coupled receptor, PFI-014 |
| 05/02/2001 | EP1095657A2 Compositions for the regulation of cytokine activity |
| 05/02/2001 | EP1095057A1 Matrix metalloproteinase inhibitors containing aminomalonic acid derivatives and peptide backbone modified derivatives thereof |
| 05/02/2001 | EP1095038A1 Antagonists of gonadotropin releasing hormone |
| 05/02/2001 | EP1095037A1 Improved process of synthesis of 5-methoxy- 2- (4-methoxy- 3,5-dimethyl- 2-pyridyl)methyl]sulfinyl-1h-benzimidazole |
| 05/02/2001 | EP1095036A1 Cinnamic acid derivatives as cell adhesion molecules |
| 05/02/2001 | EP1095031A1 Antiviral macrocyclic compounds |
| 05/02/2001 | EP1095021A1 Quinoline derivatives |
| 05/02/2001 | EP1095016A1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 05/02/2001 | EP1095015A2 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
| 05/02/2001 | EP1095003A1 Cytokine production and tyrosine kinase inhibitors |
| 05/02/2001 | EP1094834A1 Pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome and new use of substances therein |
| 05/02/2001 | EP1094810A1 Use of prenyltransferase inhibitors for preparing a medicine for treating pathologies resulting from heterotrimeric g protein membrane fixation |
| 05/02/2001 | EP1094807A1 Vitamin e and esters thereof for use in the topical treatment of mucosal pathologies |